Breast Cancer Treatment: Dramatic Shrinking Seen In Cancer Cells With Drugs

Breast cancer treatment may have a new tailored treatment if this accidental discovery makes its way to become a mainstream methodology. UK doctors looking at the way drugs make a difference between the time when a cancer is diagnosed and its removal, this new discovery was made. The doctors found that in some patients who were put on two drugs – lapatinib and trastuzumab – showed no sign of cancer when they were brought to the surgeons for their operation. According to Professor Judith Bliss, from the Institute of Cancer Research in London, the “impact was dramatic”. Talking to the BBC website, she said, “We were particularly surprised by these findings as this was a short-term trial. It became apparent some had a complete response. It’s absolutely intriguing, it is so fast.”Like us on Facebook Breat cancer treatment to change? Trastuzumab, also known as Herceptin is said to work on the surface of cancer cells while Lapatinib enters the cells and attacks the protein responsible for fuelling the growth of cancer – HER2. Breast Cancer Prevention: Broccoli May Help Slow Growth Of Cancer Cells The breast cancer treatment which began on women with 1 to 3 cm cancerous tumor, after two weeks showed no trace of cancer cells in 11 percent of women and some 17 percent women saw the tumor size go down to 5 mm in size. Though this is a tremendous encouraging result, doctors are cautious. They say that the results would require further investigation and trails to arrive at its use as a mainline treatment. At present, the line of treatment for HER2 positive cancer involves surgery and chemotherapy with Herceptin. The present finding could mean that some women may not need surgery, says Prof Bliss. However, he adds that they would need to do extensive research to come to such a decision as HER2 cancers have a reputation of returning. “We would have to be very clear we’re not taking a backwards step and increasing the risk of relapse,” Prof Bliss added. At present, breast cancer is a sum of some 10 types of conditions and each require different line of treatment. According to Baroness Delyth Morgan, the chief executive at Breast Cancer Now, “We hope this particularly impressive combination trial will serve as a stepping stone to an era of more personalized treatment for HER2 positive breast cancer.” Photo: Pixabay, Pixabay

Breast Cancer Treatment: Dramatic Shrinking Seen In Cancer Cells With Drugs

Breast cancer treatment may have a new tailored treatment if this accidental discovery makes its way to become a mainstream methodology. UK doctors looking at the way drugs make a difference between the time when a cancer is diagnosed and its removal, this new discovery was made. The doctors found that in some patients who were put on two drugs – lapatinib and trastuzumab – showed no sign of cancer when they were brought to the surgeons for their operation. According to Professor Judith Bliss, from the Institute of Cancer Research in London, the “impact was dramatic”. Talking to the BBC website, she said, “We were particularly surprised by these findings as this was a short-term trial. It became apparent some had a complete response. It’s absolutely intriguing, it is so fast.”Like us on Facebook Breat cancer treatment to change? Trastuzumab, also known as Herceptin is said to work on the surface of cancer cells while Lapatinib enters the cells and attacks the protein responsible for fuelling the growth of cancer – HER2. Breast Cancer Prevention: Broccoli May Help Slow Growth Of Cancer Cells The breast cancer treatment which began on women with 1 to 3 cm cancerous tumor, after two weeks showed no trace of cancer cells in 11 percent of women and some 17 percent women saw the tumor size go down to 5 mm in size. Though this is a tremendous encouraging result, doctors are cautious. They say that the results would require further investigation and trails to arrive at its use as a mainline treatment. At present, the line of treatment for HER2 positive cancer involves surgery and chemotherapy with Herceptin. The present finding could mean that some women may not need surgery, says Prof Bliss. However, he adds that they would need to do extensive research to come to such a decision as HER2 cancers have a reputation of returning. “We would have to be very clear we’re not taking a backwards step and increasing the risk of relapse,” Prof Bliss added. At present, breast cancer is a sum of some 10 types of conditions and each require different line of treatment. According to Baroness Delyth Morgan, the chief executive at Breast Cancer Now, “We hope this particularly impressive combination trial will serve as a stepping stone to an era of more personalized treatment for HER2 positive breast cancer.” Photo: Pixabay, Pixabay

Breast Cancer Treatment: Dramatic Shrinking Seen In Cancer Cells With Drugs

Breast cancer treatment may have a new tailored treatment if this accidental discovery makes its way to become a mainstream methodology. UK doctors looking at the way drugs make a difference between the time when a cancer is diagnosed and its removal, this new discovery was made. The doctors found that in some patients who were put on two drugs – lapatinib and trastuzumab – showed no sign of cancer when they were brought to the surgeons for their operation. According to Professor Judith Bliss, from the Institute of Cancer Research in London, the “impact was dramatic”. Talking to the BBC website, she said, “We were particularly surprised by these findings as this was a short-term trial. It became apparent some had a complete response. It’s absolutely intriguing, it is so fast.”Like us on Facebook Breat cancer treatment to change? Trastuzumab, also known as Herceptin is said to work on the surface of cancer cells while Lapatinib enters the cells and attacks the protein responsible for fuelling the growth of cancer – HER2. Breast Cancer Prevention: Broccoli May Help Slow Growth Of Cancer Cells The breast cancer treatment which began on women with 1 to 3 cm cancerous tumor, after two weeks showed no trace of cancer cells in 11 percent of women and some 17 percent women saw the tumor size go down to 5 mm in size. Though this is a tremendous encouraging result, doctors are cautious. They say that the results would require further investigation and trails to arrive at its use as a mainline treatment. At present, the line of treatment for HER2 positive cancer involves surgery and chemotherapy with Herceptin. The present finding could mean that some women may not need surgery, says Prof Bliss. However, he adds that they would need to do extensive research to come to such a decision as HER2 cancers have a reputation of returning. “We would have to be very clear we’re not taking a backwards step and increasing the risk of relapse,” Prof Bliss added. At present, breast cancer is a sum of some 10 types of conditions and each require different line of treatment. According to Baroness Delyth Morgan, the chief executive at Breast Cancer Now, “We hope this particularly impressive combination trial will serve as a stepping stone to an era of more personalized treatment for HER2 positive breast cancer.” Photo: Pixabay, Pixabay

Breast Cancer Treatment: Dramatic Shrinking Seen In Cancer Cells With Drugs

Breast cancer treatment may have a new tailored treatment if this accidental discovery makes its way to become a mainstream methodology. UK doctors looking at the way drugs make a difference between the time when a cancer is diagnosed and its removal, this new discovery was made. The doctors found that in some patients who were put on two drugs – lapatinib and trastuzumab – showed no sign of cancer when they were brought to the surgeons for their operation. According to Professor Judith Bliss, from the Institute of Cancer Research in London, the “impact was dramatic”. Talking to the BBC website, she said, “We were particularly surprised by these findings as this was a short-term trial. It became apparent some had a complete response. It’s absolutely intriguing, it is so fast.”Like us on Facebook Breat cancer treatment to change? Trastuzumab, also known as Herceptin is said to work on the surface of cancer cells while Lapatinib enters the cells and attacks the protein responsible for fuelling the growth of cancer – HER2. Breast Cancer Prevention: Broccoli May Help Slow Growth Of Cancer Cells The breast cancer treatment which began on women with 1 to 3 cm cancerous tumor, after two weeks showed no trace of cancer cells in 11 percent of women and some 17 percent women saw the tumor size go down to 5 mm in size. Though this is a tremendous encouraging result, doctors are cautious. They say that the results would require further investigation and trails to arrive at its use as a mainline treatment. At present, the line of treatment for HER2 positive cancer involves surgery and chemotherapy with Herceptin. The present finding could mean that some women may not need surgery, says Prof Bliss. However, he adds that they would need to do extensive research to come to such a decision as HER2 cancers have a reputation of returning. “We would have to be very clear we’re not taking a backwards step and increasing the risk of relapse,” Prof Bliss added. At present, breast cancer is a sum of some 10 types of conditions and each require different line of treatment. According to Baroness Delyth Morgan, the chief executive at Breast Cancer Now, “We hope this particularly impressive combination trial will serve as a stepping stone to an era of more personalized treatment for HER2 positive breast cancer.” Photo: Pixabay, Pixabay

Breast Cancer Treatment: Dramatic Shrinking Seen In Cancer Cells With Drugs

Breast cancer treatment may have a new tailored treatment if this accidental discovery makes its way to become a mainstream methodology. UK doctors looking at the way drugs make a difference between the time when a cancer is diagnosed and its removal, this new discovery was made. The doctors found that in some patients who were put on two drugs – lapatinib and trastuzumab – showed no sign of cancer when they were brought to the surgeons for their operation. According to Professor Judith Bliss, from the Institute of Cancer Research in London, the “impact was dramatic”. Talking to the BBC website, she said, “We were particularly surprised by these findings as this was a short-term trial. It became apparent some had a complete response. It’s absolutely intriguing, it is so fast.”Like us on Facebook Breat cancer treatment to change? Trastuzumab, also known as Herceptin is said to work on the surface of cancer cells while Lapatinib enters the cells and attacks the protein responsible for fuelling the growth of cancer – HER2. Breast Cancer Prevention: Broccoli May Help Slow Growth Of Cancer Cells The breast cancer treatment which began on women with 1 to 3 cm cancerous tumor, after two weeks showed no trace of cancer cells in 11 percent of women and some 17 percent women saw the tumor size go down to 5 mm in size. Though this is a tremendous encouraging result, doctors are cautious. They say that the results would require further investigation and trails to arrive at its use as a mainline treatment. At present, the line of treatment for HER2 positive cancer involves surgery and chemotherapy with Herceptin. The present finding could mean that some women may not need surgery, says Prof Bliss. However, he adds that they would need to do extensive research to come to such a decision as HER2 cancers have a reputation of returning. “We would have to be very clear we’re not taking a backwards step and increasing the risk of relapse,” Prof Bliss added. At present, breast cancer is a sum of some 10 types of conditions and each require different line of treatment. According to Baroness Delyth Morgan, the chief executive at Breast Cancer Now, “We hope this particularly impressive combination trial will serve as a stepping stone to an era of more personalized treatment for HER2 positive breast cancer.” Photo: Pixabay, Pixabay

Breast Cancer Treatment: Dramatic Shrinking Seen In Cancer Cells With Drugs

Breast cancer treatment may have a new tailored treatment if this accidental discovery makes its way to become a mainstream methodology. UK doctors looking at the way drugs make a difference between the time when a cancer is diagnosed and its removal, this new discovery was made. The doctors found that in some patients who were put on two drugs – lapatinib and trastuzumab – showed no sign of cancer when they were brought to the surgeons for their operation. According to Professor Judith Bliss, from the Institute of Cancer Research in London, the “impact was dramatic”. Talking to the BBC website, she said, “We were particularly surprised by these findings as this was a short-term trial. It became apparent some had a complete response. It’s absolutely intriguing, it is so fast.”Like us on Facebook Breat cancer treatment to change? Trastuzumab, also known as Herceptin is said to work on the surface of cancer cells while Lapatinib enters the cells and attacks the protein responsible for fuelling the growth of cancer – HER2. Breast Cancer Prevention: Broccoli May Help Slow Growth Of Cancer Cells The breast cancer treatment which began on women with 1 to 3 cm cancerous tumor, after two weeks showed no trace of cancer cells in 11 percent of women and some 17 percent women saw the tumor size go down to 5 mm in size. Though this is a tremendous encouraging result, doctors are cautious. They say that the results would require further investigation and trails to arrive at its use as a mainline treatment. At present, the line of treatment for HER2 positive cancer involves surgery and chemotherapy with Herceptin. The present finding could mean that some women may not need surgery, says Prof Bliss. However, he adds that they would need to do extensive research to come to such a decision as HER2 cancers have a reputation of returning. “We would have to be very clear we’re not taking a backwards step and increasing the risk of relapse,” Prof Bliss added. At present, breast cancer is a sum of some 10 types of conditions and each require different line of treatment. According to Baroness Delyth Morgan, the chief executive at Breast Cancer Now, “We hope this particularly impressive combination trial will serve as a stepping stone to an era of more personalized treatment for HER2 positive breast cancer.” Photo: Pixabay, Pixabay

Alcohol Can Trigger Cancer-Causing Gene, Increase Breast Cancer Risk In Women: Study

Alcohol consumption has been found to increase the risk of breast cancer as it can boost the actions of estrogen driving the growth of breast cancer cells. A new study shows alcohol can also trigger a cancer-causing gene and cut the ability of a drug that blocks the rapid growth of cancer cells. The study, published in the journal PLOS ONE, shows alcohol can increase the levels of a cancer-causing gene known as BRAF and promote its sustained expression. Alcohol can also reduce the effectiveness of the drug Tamoxifen that fights cancer cell growth. However, even with the absence of estrogen, researchers from the University of Houston said alcohol can still mimic or enhance the effects of estrogen which can increase breast cancer risk. According to the researchers, an estimated tens of thousands of breast cancer cases in the US and Europe every year are linked to alcohol consumption. In addition, women with early stage breast cancer who drink alcohol were found to be at an increased risk of disease recurrence.Like us on Facebook Researchers said the findings may help boost cancer prevention. In addition, the study may significantly help women undergoing hormone replacement therapy for menopausal symptoms, as “alcohol can affect the actions of the hormones they take to manage their symptoms.” Why Breast Cancer Among Pregnant Women On Rise In The UK Researcher Chin-Yo Lin, a cancer biologist at the University of Houston, also added the study may help college-age women and those experiencing heavy or binge drinking as part of their social environment. “We hope these and future findings will provide information and motivation to promote healthy behavioral choices, as well as potential targets for chemo prevention strategies to ultimately decrease breast cancer incidents and deaths within the next decade,” Lin said. “We want to provide women, in general, with more information and insight to be better able to balance their consumption of alcoholic beverages with the potential health risks, including cancer patients who may want to take into consideration the potential detrimental effects alcohol consumption might have on treatments and modify their behavior and habits accordingly,” he added. Photo Source: Pexels, Wikimedia,

Alcohol Can Trigger Cancer-Causing Gene, Increase Breast Cancer Risk In Women: Study

Alcohol consumption has been found to increase the risk of breast cancer as it can boost the actions of estrogen driving the growth of breast cancer cells. A new study shows alcohol can also trigger a cancer-causing gene and cut the ability of a drug that blocks the rapid growth of cancer cells. The study, published in the journal PLOS ONE, shows alcohol can increase the levels of a cancer-causing gene known as BRAF and promote its sustained expression. Alcohol can also reduce the effectiveness of the drug Tamoxifen that fights cancer cell growth. However, even with the absence of estrogen, researchers from the University of Houston said alcohol can still mimic or enhance the effects of estrogen which can increase breast cancer risk. According to the researchers, an estimated tens of thousands of breast cancer cases in the US and Europe every year are linked to alcohol consumption. In addition, women with early stage breast cancer who drink alcohol were found to be at an increased risk of disease recurrence.Like us on Facebook Researchers said the findings may help boost cancer prevention. In addition, the study may significantly help women undergoing hormone replacement therapy for menopausal symptoms, as “alcohol can affect the actions of the hormones they take to manage their symptoms.” Why Breast Cancer Among Pregnant Women On Rise In The UK Researcher Chin-Yo Lin, a cancer biologist at the University of Houston, also added the study may help college-age women and those experiencing heavy or binge drinking as part of their social environment. “We hope these and future findings will provide information and motivation to promote healthy behavioral choices, as well as potential targets for chemo prevention strategies to ultimately decrease breast cancer incidents and deaths within the next decade,” Lin said. “We want to provide women, in general, with more information and insight to be better able to balance their consumption of alcoholic beverages with the potential health risks, including cancer patients who may want to take into consideration the potential detrimental effects alcohol consumption might have on treatments and modify their behavior and habits accordingly,” he added. Photo Source: Pexels, Wikimedia,

Alcohol Can Trigger Cancer-Causing Gene, Increase Breast Cancer Risk In Women: Study

Alcohol consumption has been found to increase the risk of breast cancer as it can boost the actions of estrogen driving the growth of breast cancer cells. A new study shows alcohol can also trigger a cancer-causing gene and cut the ability of a drug that blocks the rapid growth of cancer cells. The study, published in the journal PLOS ONE, shows alcohol can increase the levels of a cancer-causing gene known as BRAF and promote its sustained expression. Alcohol can also reduce the effectiveness of the drug Tamoxifen that fights cancer cell growth. However, even with the absence of estrogen, researchers from the University of Houston said alcohol can still mimic or enhance the effects of estrogen which can increase breast cancer risk. According to the researchers, an estimated tens of thousands of breast cancer cases in the US and Europe every year are linked to alcohol consumption. In addition, women with early stage breast cancer who drink alcohol were found to be at an increased risk of disease recurrence.Like us on Facebook Researchers said the findings may help boost cancer prevention. In addition, the study may significantly help women undergoing hormone replacement therapy for menopausal symptoms, as “alcohol can affect the actions of the hormones they take to manage their symptoms.” Why Breast Cancer Among Pregnant Women On Rise In The UK Researcher Chin-Yo Lin, a cancer biologist at the University of Houston, also added the study may help college-age women and those experiencing heavy or binge drinking as part of their social environment. “We hope these and future findings will provide information and motivation to promote healthy behavioral choices, as well as potential targets for chemo prevention strategies to ultimately decrease breast cancer incidents and deaths within the next decade,” Lin said. “We want to provide women, in general, with more information and insight to be better able to balance their consumption of alcoholic beverages with the potential health risks, including cancer patients who may want to take into consideration the potential detrimental effects alcohol consumption might have on treatments and modify their behavior and habits accordingly,” he added. Photo Source: Pexels, Wikimedia,

Breast Cancer Treatment: Dramatic Shrinking Seen In Cancer Cells With Drugs

Breast cancer treatment may have a new tailored treatment if this accidental discovery makes its way to become a mainstream methodology. UK doctors looking at the way drugs make a difference between the time when a cancer is diagnosed and its removal, this new discovery was made. The doctors found that in some patients who were put on two drugs – lapatinib and trastuzumab – showed no sign of cancer when they were brought to the surgeons for their operation. According to Professor Judith Bliss, from the Institute of Cancer Research in London, the “impact was dramatic”. Talking to the BBC website, she said, “We were particularly surprised by these findings as this was a short-term trial. It became apparent some had a complete response. It’s absolutely intriguing, it is so fast.”Like us on Facebook Breat cancer treatment to change? Trastuzumab, also known as Herceptin is said to work on the surface of cancer cells while Lapatinib enters the cells and attacks the protein responsible for fuelling the growth of cancer – HER2. Breast Cancer Prevention: Broccoli May Help Slow Growth Of Cancer Cells The breast cancer treatment which began on women with 1 to 3 cm cancerous tumor, after two weeks showed no trace of cancer cells in 11 percent of women and some 17 percent women saw the tumor size go down to 5 mm in size. Though this is a tremendous encouraging result, doctors are cautious. They say that the results would require further investigation and trails to arrive at its use as a mainline treatment. At present, the line of treatment for HER2 positive cancer involves surgery and chemotherapy with Herceptin. The present finding could mean that some women may not need surgery, says Prof Bliss. However, he adds that they would need to do extensive research to come to such a decision as HER2 cancers have a reputation of returning. “We would have to be very clear we’re not taking a backwards step and increasing the risk of relapse,” Prof Bliss added. At present, breast cancer is a sum of some 10 types of conditions and each require different line of treatment. According to Baroness Delyth Morgan, the chief executive at Breast Cancer Now, “We hope this particularly impressive combination trial will serve as a stepping stone to an era of more personalized treatment for HER2 positive breast cancer.” Photo: Pixabay, Pixabay